# Annaida Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/annaida-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Lausanne, Switzerland
- Website: www.annaida.ch/
- Total disclosed funding: $1M
- Latest round: Seed (Mar 31, 2020)
- Investors on record: 6

## About

Founded in 2019 and based in Lausanne, Switzerland, Annaida Technologies SA is a health technology company focused on the development of human embryo assays through metabolic non-invasive screening to support drug development studies. The company was co-founded by its CEO, Marco Grisi, and others. In?April 2025,?Annaida Technologies SA?raised?an undisclosed amount of pre-series A funding?led by returning investor Hemex AG, with participation from other returning investors Zürcher Kantonalbank, Excellis, EFI Lake Geneva Ventures, Club Degli Investitori, and Innosuisse. New investor European Innovation Council and other unspecified investors also participated in the round. The company’s primary product includes EmbryoSpin, which that utilizes micro-magnetic resonance spectroscopy (MRS) to offer insights into cellular metabolism, applicable from embryos to stem-cell organoids. This device enhances research in toxicology, drug discovery, and life sciences by providing detailed metabolic profiling without compromising cellular integrity. EmbryoSpin's technology is beneficial for fertility clinics, improving embryo selection and boosting outcomes in Assisted Reproductive Therapy (ART). The company plans to utilize the April 2025 funding to assist product development, marketing, regulatory validation, and intellectual property.

## Funding rounds

- Seed, Mar 31, 2020, $1M — Zürcher Kantonalbank, Fongit Seed Invest, Business Angels Suisse, Venture Kick, Privilege Ventures, Hemex AG

## Investors

- Zürcher Kantonalbank — Seed
- Fongit Seed Invest (https://capitalatlas.ai/funds/fongit-seed-invest) — Seed
- Business Angels Suisse — Seed
- Venture Kick (https://capitalatlas.ai/funds/venture-kick) — Seed
- Privilege Ventures (https://capitalatlas.ai/funds/privilege-ventures) — Seed
- Hemex AG (https://capitalatlas.ai/funds/hemex-ag) — Seed